Literature DB >> 34981192

Genetic analysis of a malignant meningioma and associated metastases.

Kristin Huntoon1,2, Ayse Selen Yilmaz3, Maciej Pietrzak3, Xi Chen4, Pearlly Yan4, Amanda Ewart Toland5, J Bradley Elder6.   

Abstract

To identify genes altered in a highly aggressive metastatic meningioma primary as well as its metastases. Exome sequencing of a primary anaplastic meningioma and metastatic lesions in which DNA could be extracted and compared to germline DNA. Genetic analysis of the metastatic sites found 31 common mutations among the primary tumor and two metastatic sites. Additionally, genetic mutations were identified which were either infrequently (MUC3A, ALDH1A3, HOXA1) or not at all previously described in meningiomas (CASS4, CMKLR1). Exome sequencing of a metastatic meningioma and its distant metastases outside the CNS identified mutations that were not previously well described.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Extracranial meningioma; Metastatic meningioma

Mesh:

Year:  2022        PMID: 34981192     DOI: 10.1007/s00701-021-05101-w

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

Authors:  Daniel C Koboldt; Qunyuan Zhang; David E Larson; Dong Shen; Michael D McLellan; Ling Lin; Christopher A Miller; Elaine R Mardis; Li Ding; Richard K Wilson
Journal:  Genome Res       Date:  2012-02-02       Impact factor: 9.043

2.  HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer.

Authors:  Jintao Liu; Jinquan Liu; Xinyi Lu
Journal:  Exp Ther Med       Date:  2018-12-28       Impact factor: 2.447

3.  Loss of heterozygosity studies in extracranial metastatic meningiomas.

Authors:  Caroline Regna Gladin; Ettore Salsano; Francesca Menghi; Marina Grisoli; Francesco Ghielmetti; Ida Milanesi; Bianca Pollo; Stefano Brock; Alberto Cusin; Ludovico Minati; Gaetano Finocchiaro; Maria Grazia Bruzzone
Journal:  J Neurooncol       Date:  2007-04-24       Impact factor: 4.130

4.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

5.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

6.  New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses.

Authors:  Aysha AlSahlawi; Rasha Aljelaify; Malak Abedalthagafi; Amna Magrashi; Mariam AlSaeed; Amal Almutairi; Fatimah Alqubaishi; Abdulellah Alturkistani; Abdullah AlObaid; Mohamed Abouelhoda; Latifa AlMubarak; Nada AlTassan
Journal:  Oncotarget       Date:  2019-09-17

7.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

8.  The Ensembl Variant Effect Predictor.

Authors:  William McLaren; Laurent Gil; Sarah E Hunt; Harpreet Singh Riat; Graham R S Ritchie; Anja Thormann; Paul Flicek; Fiona Cunningham
Journal:  Genome Biol       Date:  2016-06-06       Impact factor: 13.583

9.  Expression of ZFX gene correlated with the central features of the neoplastic phenotype in human brain tumors with distinct phenotypes.

Authors:  Azita Afzali; Modjtaba Emadi-Baygi; Parvaneh Nikpour; Fatemehe Nazemroaya; Majid Kheirollahi
Journal:  Adv Biomed Res       Date:  2015-08-31

10.  An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.

Authors:  Grace Collord; Patrick Tarpey; Natalja Kurbatova; Inigo Martincorena; Sebastian Moran; Manuel Castro; Tibor Nagy; Graham Bignell; Francesco Maura; Matthew D Young; Jorge Berna; Jose M C Tubio; Chris E McMurran; Adam M H Young; Mathijs Sanders; Imran Noorani; Stephen J Price; Colin Watts; Elke Leipnitz; Matthias Kirsch; Gabriele Schackert; Danita Pearson; Abel Devadass; Zvi Ram; V Peter Collins; Kieren Allinson; Michael D Jenkinson; Rasheed Zakaria; Khaja Syed; C Oliver Hanemann; Jemma Dunn; Michael W McDermott; Ramez W Kirollos; George S Vassiliou; Manel Esteller; Sam Behjati; Alvis Brazma; Thomas Santarius; Ultan McDermott
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

View more
  1 in total

1.  P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas.

Authors:  Dimitrios Roukas; Anastasios Kouzoupis; Despoina Spyropoulou; George Papanastasiou; Evangelos Tsiambas; George Tsouvelas; Evangelos Falidas; Vasileios Ragos; Dimitrios Peschos; Loukas Manaios; Spyros Katsinis; Arezina Manoli; Sotirios Papouliakos; Andreas C Lazaris; Nikolaos Kavantzas
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.